Poster Submissions
13-16 October 2025
RAI Congress Centre, Amsterdam
The deadline for Scientific Poster Submissions was the 15th October 2025. Thank you to everyone who has submitted a poster.
All posters will be displayed in the congress exhibition hall and will stay up throughout the congress Tuesday 14 - Thursday 16 October. If you are listed below please arrive on the morning of Tuesday 14 October to display them up on the boards within the Poster Zone.
We are also promoting all attendees to visit the Poster Zone at: 13:30 on Tuesday 14 Oct, 13:45 on Wednesday 15 Oct and 11:30 on Thursday 16 Oct. Poster presenters should be stationed next to their posters at these times.
| Author | Organization or Academic Institution | Poster Title |
|---|---|---|
| Willemijn Rijnink | Erasmus Medical Center | A Novel Antigenically Central HA mRNA Vaccine Confers Humoral and Cellular Immune Responses and Protects Ferrets against Challenge with a Heterologous A(H5) Clade 2.3.4.4b Highly Pathogenic Avian Influenza Virus |
| Turelli Priscilla | EPFL | Antigenic landscape of a highly mutated SARS-CoV-2 Spike in ongoing viral evolution |
| Minkyung Kim | Yonsei University | Transdermal Bacillus Calmette–Guérin Immunization Using Functionally Diversified Dissolving Microneedles (FDMN): Design, Protective Performance, and Stability |
| Camilla Di Giulio | EPFL | Decoding the Molecular Mechanisms Behind Antibody-Dependent Enhancement in Dengue Virus |
| Fabio Balzarini | Amsterdam UMC | Glycosylated and size-controlled PLGA improve antigen presentation through DC-SIGN targeting in the context of therapeutic cancer vaccination |
| Jeehye Nam | Yonsei University | Dissolving Microneedle-based Epicutaneous Immunotherapy for Peanut Allergy Using a Film-Gluing Method |
| Jeff Higgins | GEOPH - Geospatial Public Health | A pilot project to test the feasibility of Vaccine Buddy data collection devices in polio house-to-house vaccination campaigns in Nigeria and Democratic Republic of the Congo |
| Leon de Waal | Cerba Research | Highly Pathogenic Avian Influenza Virus A/H5N1 subclade 2.3.4.4 b isolated from a European grey seal (Halichoerus grypus) is highly virulent in ferrets |
| Arto A. Palmu | FVR - Finnish Vaccine Research | FVR - Finnish Vaccine Research: Real-world evidence (RWE) opportunities to evaluate vaccine effectiveness, safety and disease burden – a frontrunner before EHDS |
| Winnie Kerstens | KU Leuven | ArboSero – Development of a Validated and High-Throughput Arbovirus Serology Platform |
| Erwan Le Dault | French Armed Forces Biomedical Research Institute, French Military Health Service | Unmasking the variables: lessons from in vitro models of vaccine-induced trained immunity |
| Koen Beyers | Idevax | An innovative Approach to Pandemic Preparedness and Shortages in Supply through Intradermal Dose-Sparing and Remote Manufacturing |
| Colin Venner | Thermo Fisher Scientific | Exploring the Role of Recombinant Protease in Bioproduction: Influenza Hemagglutinin Cleavage, Enzyme Dilution, and Carryover Effects |
| Julia Romanova | Capricorn Technologies GmbH | UniFluVec: An Intranasal Influenza Vector Enabling Cross-Protection after Single Intranasal Dose |
| Aloys Tijsma | Cerba Research | Qualification of Microneutralization Assays for HMPV and HPIV-3: Robust Tools for Clinical Vaccine Evaluation |
| Jae Young Kim | Center for FMD Vaccine Research, Animal and Plant Quarantine Agency | Exploring the Role of Recombinant Protease in Bioproduction: Influenza Hemagglutinin Cleavage, Enzyme Dilution, and Carryover Effects |
| Rizky Andreasari | Infectious Disease Alliance (IDA) | Precision Public Engagement to Overcome Vaccine Hesitancy: A Policy Model to Support Global Vaccine Equity |
| Christine Langer | Burnet Institute | Thermostable Pan-βCoV Subunit Vaccines: A Cold Chain-Free Solution for Future Coronavirus Pandemics |
| Oliver Varette | Virica Biotech | Development and Scale Up Validation of Small Molecule Cell Enhancers for Improved Viral Vaccine Manufacturing |
| Yannick Marrari | Bio-Rad | Development of a cGMP-Ready Purification Process for Adenovirus Purification |
| Wang Nguitragool | Mahidol University | Advancing Multistage mRNA Vaccine Development Against Plasmodium vivax: From Novel Antigen Design to Preclinical Progress |
| Jihyeon Hwang | Animal and plant quarantine agency | Intradermal administration of the ISA 207 adjuvant enhances the efficacy of foot-and-mouth disease vaccine in pigs |
| Astrid de Greeff | Wageningen Bioveterinary Research | European Veterinary Big Data Landscape to Support Regulatory Activities |
| Ilona Schmidt | FVR-Finnish Vaccine Research | FVR – Finnish Vaccine Research: From Research to Public Health Impact: Marketing Authorization Outcomes of Prelicensure Vaccine Trials Conducted in Finland |
| Mats Lundgren | Abera Bioscience AB | Intranasal influenza vaccination using Abera’s Outer Membrane Vesicle platform |
| Ali Shamani | University of Turku | Repeated Pertussis Booster Vaccination in Healthcare Professionals: the Effect on Magnitude, Functionality and Durability of Antibody Responses |
| Emanuele sasso | University of Naples Federico II - ImGen-T | Novel encoded adjuvants for genetic vaccines |
| Žana Morel | Sartoriu BIA Separations | Monitoring Orf Virus Production with PATfix Analytical Method |
| Alex Olvera van der Stoep | IrsiCaixa | The BCN03 clinical trial: Combining T- and B-cell HIV Immunogens as Therapeutic Vaccines |
| Mark Fife | Glen Clova Scientific | Virus-Like Particle (VLP) based Vaccine Therapy for Chronic Itch: A Novel Immunotherapeutic Approach |
| Miran Jo | NIFDS | The standardization of the RNA content test and the encapsulation percentage test for mRNA vaccine. |
| Viani Figueroa | Signant Health | The Power of the Prompt: Effect of Alarms on Electronic Diary Completion in Vaccine Trials |
| Nicolas Heureux | Kimialys | K-One Surface Chemistry: Enabling Antibody Discovery and Vaccine Research with SPR Biochips and Nanoparticle Platforms |
| Julien Flaig | Spegegant | When vaccine clinical trials fail to support decision-making, and what to do about it |
| Saana Soppela | Tampere University | Coxsackie B1 virus-like particle vaccine modified to exclude a highly conserved immunoreactive region from the capsid induces potent neutralizing antibodies and protects against infection in mice |
| Heini Lehto | Tampere University | Intranasal protein-based COVID-19 vaccine induces superior mucosal and cellular immunity compared to commercial mRNA vaccine |
| Bruno Tillier | Synthelis Biotech | Integrated High-Throughput Protein Expression Platform combining cell-free and bioluminescence technologies with Artificial Intelligence (AI) |
| Nele Verheyen | SGS Belgium NV | Understanding Vaccine Hesitancy Among Healthy Trial Participants |
| Gyeongmin Lee | Animal and Plant Quarantine Agency | Enhanced production of SAT1 and SAT3 serotype foot-and-mouth disease antigens by calcium chloride supplementation in BHK-21 suspension cultures |
| Peter Nicholson | PharmaLatch | Redefining Intradermal Delivery with Proven, Next-Gen Performance |
| Karen Einsfeldt | Thermo Fisher Scientific | Minimizing Serum Use in Vaccine Manufacturing with Peptones |
| Dusan Raicevic | UniverCells Technologies by Donaldson | Next-Generation Vaccine Manufacturing: Producing Millions of Doses in a Compact Footprint with Drastic Cost Reduction |
| Mark Emalfarb | Dyadic Applied BioSolutions | Development of the C1 TECHNOLOGY for the production of prophylactic mAbs and vaccines |
| Hyejin Kim | Animal and Plant Quarantine Agency (APQA), Republic of Korea | Rapid NanoBiT-based neutralizing antibodies assay using HiBiT-tagged virus-like particles of foot-and-mouth disease serotype O |
| Damian Alvarez-Paggi | Eureka Nanobioengineering | A Modular Self-Assembling Platform for Next-Gen Immunoengineering |
| Berenguela Ortega Molina | InVitria | Formulation of a blood-free and cdm production media for VERO cells |
| Marcus Curl | InVitria | ADDRESSING VACCINE STABILITY AND COLD CHAIN CHALLENGES WITH RECOMBINANT HUMAN SERUM ALBUMIN TO ENABLE GLOBAL ADMINISTRATION |
| Maggie Haitian Wang | The Chinese University of Hong Kong | PCO – A highly effective codon optimization strategy for improving protein expression of vaccines of different platforms |
| Stina Gröhn | Tampere University | Nucleoprotein acts as a booster for spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine |
| Olha Bondarenko | World Health Organization Ukraine | Targeting barriers to vaccination among internally displaced persons near the frontline areas of Ukraine |
| Alsya Affandi | Amsterdam UMC | CD169/Siglec-1-guided VHH vaccine platform for cancer immunotherapy |
| Ivo Ploemen | Praetorian Bio | Development of Broadly Protective Vaccines Targeting Oral Pathogens to Prevent Caries and Periodontitis |
| Elly van Riet | AIGHD | TETRALITE, an accessible seasonal flu vaccine with high efficacy at low cost |
| Dinja Oosterhoff | C-Mark Bio | Cer |
| Karen Einsfeldt | Thermo Fisher Scientific | Minimizing Serum Use in Vaccine Manufacturing with Peptones |
| Dusan Raicevic | UniverCells Technologies by Donaldson | Next-Generation Vaccine Manufacturing: Producing Millions of Doses in a Compact Footprint with Drastic Cost Reduction |
| Mark Emalfarb | Dyadic Applied BioSolutions | Development of the C1 TECHNOLOGY for the production of prophylactic mAbs and vaccines |
| Hyejin Kim | Animal and Plant Quarantine Agency (APQA), Republic of Korea | Rapid NanoBiT-based neutralizing antibodies assay using HiBiT-tagged virus-like particles of foot-and-mouth disease serotype O |
| Damian Alvarez-Paggi | Eureka Nanobioengineering | A Modular Self-Assembling Platform for Next-Gen Immunoengineering |
| Berenguela Ortega Molina | InVitria | Formulation of a blood-free and cdm production media for VERO cells |
| Marcus Curl | InVitria | ADDRESSING VACCINE STABILITY AND COLD CHAIN CHALLENGES WITH RECOMBINANT HUMAN SERUM ALBUMIN TO ENABLE GLOBAL ADMINISTRATION |
| Maggie Haitian Wang | The Chinese University of Hong Kong | PCO – A highly effective codon optimization strategy for improving protein expression of vaccines of different platforms |
| Stina Gröhn | Tampere University | Nucleoprotein acts as a booster for spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine |
| Olha Bondarenko | World Health Organization Ukraine | Targeting barriers to vaccination among internally displaced persons near the frontline areas of Ukraine |
| Alsya Affandi | Amsterdam UMC | CD169/Siglec-1-guided VHH vaccine platform for cancer immunotherapy |
| Ivo Ploemen | Praetorian Bio | Development of Broadly Protective Vaccines Targeting Oral Pathogens to Prevent Caries and Periodontitis |
| Elly van Riet | AIGHD | TETRALITE, an accessible seasonal flu vaccine with high efficacy at low cost |
| Dinja Oosterhoff | C-Mark Bio | Ceramic Microneedle Array Patches for Intradermal Delivery of Vaccines |
| Cora Mibus | Technische Universität München | Evaluation of fusion antigens as prophylactic anti-Helicobacter pylori vaccine |
| Annelies Turksma | Amsterdam UMC | Immune monitoring identifies Irreversible Electroporation as a means of in-vivo cancer vaccination |
| Kelly McKee | GeoVax | Interim Safety and Reactogenicity of GEO-CM04S1, an MVA-vectored, multi-antigen COVID-19 vaccine, in adults with hematologic malignancies receiving cellular therapies |
| Timothy An | Gachon university | Establishing Immune Correlates from Gardasil to Inform mRNA HPV Vaccine Evaluation |
| Nea Young Chun | MediArk | MOF-Lipid Nanoparticle Hybrid System (ARK-VAC001) for Enhanced mRNA Vaccine Delivery and Dendritic Cell Activation |
| Ryoma Nakao | Japan Institute for Health Security | LPS/Colibactin/Flagella Triple-Deficient Probiotic E. coli-derived Outer Membrane Vesicles: A Novel Nano-Particulate Vaccine Modality |
| Robert-Jan Lamers | Immundnz | Cytokine release in vaccine research |
| Denise Anabe | University of Turku | Association of HLA Class II Haplotypes with antibody concentrations after diphtheria- tetanus acellular pertussis booster vaccination in four age groups of Finnish participants |
| Florent Fordoxel | 4basebio | Harnessing synthetic DNA for scalable mRNA and DNA vaccine manufacturing |
| Dr. Babita Agrawal | University of Alberta | Design and investigation of a novel mucosal immunotherapeutic and lipopeptides-based mucosal vaccine for SARS-CoV-2 infections |
| Andrew Goodhead | Carterra | Accelerate Kinetic Screening and Epitope Characterization of Antibody Libraries with High Throughput SPR |
| Kitty Harvey | Pirbright Institute | CENTRE FOR VETERINARY VACCINE INNOVATION & MANUFACTURING (CVIM) |
| Huanhuan Li | Queen's University Belfast | A Novel Responsive Microneedle Platform for Reliable Vaccine Delivery |
| Kirsty McHugh | University of Oxford | High-Throughput SPR screening of next generation vaccine candidates for Plasmodium falciparum blood-stage malaria |
| Dr. Tahir Yousafzai | Aga Khan University | Capturing the public health impact of typhoid conjugate vaccine introduction on antimicrobial use in Pakistan |
| Hans-Peter Fasching | ViruSure GmbH | Adventitious Agent Detection by NGS |
| Allison Derenne | Spectralys Biotech | Hydrogen-Deuterium Exchange monitored by Mass Spectrometry (HDX-MS) |
| Nikita Dharmendra Tiwari | Institute of Chemical Technology, Mumbai | Intranasal Mucosal Nanovaccine for COVID-19 Infection |
| Dr Bandar Alosaimi | King Fahad Medical City | Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination |
| Bruna Machado | SENAI CIMATEC University | Design of Lipid Nanoparticles for siRNA Vaccine Delivery: Integrating Molecular Modeling and Experimental Validation |
| Yash Garodia | Ecole Polytechnique Federale de Lausanne | Structural Analyses of Polyclonal Antibody Responses Induced by Enterovirus Infections |
| Randi Nordström | RISE Research Institutes of Sweden | Effect of lipid composition on mRNA-LNP formulation stability under different storage climates |
| Kirill Dushkin | IQVIA | Harnessing Real-World Data for Vaccines in APAC and the Americas |
| Tom Bosschaerts | ImmuneWatch | Broad immunomonitoring of T-cell responses using TCR-epitope annotation solutions. |
| Maria Fernanda Pascutti | Immunotherapy Center, VUmc, Amsterdam UMC | Deep Immune Profiling of Human PBMCs Using Two Complementary Spectral Flow Cytometry Panels: Capabilities and Applications |
| Jordan Cossu | Quality Assistance | Multi-attribute monitoring of therapeutic mRNA by LC-MS |
| Kristi Prifti | International Vaccine Institute | Quantifying the Impact of Extreme Weather Events on Vaccination in Mozambique |
| Miriam Tuschy-Mori | Cytiva | Production of mRNA by in vitro transcription in a single-use system using ReadyToProcess WAVE 25 Rocker |
| Sathish Kurusamy | University of Kent | Integrated Design and Manufacturing Strategies for Next-Generation IVT RNA Vaccines: From Sequence Optimization to Scalable Production |
| Vanessa Vankerckhoven | Idevax | Evaluation of reproducibility and performance of VAX-ID, an innovative skin drug delivery device for intradermal injections |
| Christina Go | Integral Molecular | Virus Neutralization Assays in <1 Day With No Cell Culture |
| Kyle Doolan | Integral Molecular | Identifying and Engineering ZIKV E Protein Residues Responsible for DENV Cross-Reactivity to Create an Immunogen that Diminishes Anti-DENV Immune Response |
| Jack Said | Pfizer | Public Health and Economic Consequences of Delaying the Implementation of the 20-Valent Pneumococcal Conjugate Vaccine in the United Kingdom’s Paediatric National Immunisation Programme |
| Jack Said | Pfizer | Exploring the Impact of Vaccine Effectiveness Against Carriage on the Health and Economic Impact of Switching to a 20-Valent Pneumococcal Conjugate Vaccine Programme in the United Kingdom |
| Jack Said | Pfizer | AI-Powered Data Extraction for Streamlining Systematic Literature Review Delivery: a COVID-19 SLR case study |
| Jonathan Rayner | Solaris Vaccines | Shedding Light on Flu Prevention: SolaVAX Inactivation for Rapid and Effective Vaccine Production |
| Emily Dawn Kirkham | Immunoserv Ltd | Scalable standardised T cell test to assess vaccine immunogenicity and population immunity |
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events